Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
Background. A phase 3 study demonstrated the safety and efficacy of paromomycin (paromomycin IM injection) for treatment of VL in an inpatient setting. Methods. This phase 4 study was conducted to assess the safety and efficacy of paromomycin in children and adults in an outpatient setting in Bihar,...
Main Authors: | Prabhat K. Sinha, T. K. Jha, Chandreshwar P. Thakur, Devendra Nath, Supriyo Mukherjee, Amrendra Kumar Aditya, Shyam Sundar |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2011/645203 |
Similar Items
-
Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
by: Wiwanitkit V
Published: (2012-06-01) -
Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh.
by: Kazi M Jamil, et al.
Published: (2015-01-01) -
Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
by: Pashupati Pokharel, et al.
Published: (2021-01-01) -
Hearing loss associated with paromomycin treatment in a patient with visceral leishmaniasis
by: Rocio Asensi-Diez, et al.
Published: (2017-05-01) -
Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
by: Shabi Parvez, et al.
Published: (2020-07-01)